Two Sigma Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Two Sigma Securities’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,511	Closed	-$389K	–	1773
2025 Q1	$389K	Buy	+5,511	New	+$383K	0.06%	457
2018 Q2	–	Sell	-4,908	Closed	-$241K	–	2801
2018 Q1	$241K	Sell	4,908 -47,415	-91%	-$2.43M	﹤0.01%	2152
2017 Q4	$2.69M	Sell	52,323 -146,523	-74%	-$7.53M	0.07%	208
2017 Q3	$10.4M	Buy	198,846 +187,821	+1,704%	+$9.6M	0.95%	22
2017 Q2	$570K	Sell	11,025 -97,887	-90%	-$4.95M	0.11%	182
2017 Q1	$5.48M	Buy	+108,912	New	+$5.39M	1.07%	12

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Two Sigma Securities's IHE Position: Q2 2025 in Review

Two Sigma Securities sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2025, closing a stake of 5,511 shares — an estimated $389K sold.

Two Sigma Securities first reported a position in IHE in Q1 2017 and held it in 6 quarters. The position peaked at $10.4M in Q3 2017. 139 funds tracked by Wall St. Rank hold IHE as of Q2 2025.

Two Sigma Securities reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 5,511 iShares US Pharmaceuticals ETF shares in Q2 2025, an estimated $389K.
Two Sigma Securities first reported a position in iShares US Pharmaceuticals ETF in Q1 2017 and held it in 6 quarters.
Two Sigma Securities's iShares US Pharmaceuticals ETF position peaked at $10.4M in Q3 2017.
139 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.